共 108 条
[1]
Cortesi L(2006)Prognosis of screen-detected breast cancers: results of a population based study BMC Cancer 6 17-22
[2]
Chiuri VE(2004)Detection by screening mammography is a powerful independent predictor of survival in women diagnosed with breast cancer Breast 13 15-194
[3]
Ruscelli S(2014)Outcome of patients with HER2-positive breast cancer treated with or without adjuvant trastuzumab in the Finland Capecitabine Trial (FinXX) Acta Oncol 53 186-1203
[4]
Gill PG(2005)Role of detection method in predicting breast cancer survival: analysis of randomized screening trials J Natl Cancer Inst 97 1195-1744
[5]
Farshid G(2008)Screen-detected vs symptomatic breast cancer: is improved survival due to stage migration alone? Br J Cancer 98 1741-5699
[6]
Luke CG(2009)Clinical relevance of HER2 overexpression/amplification in patients with small tumor size and node-negative breast cancer J Clin Oncol 27 5693-23
[7]
Roder DM(2010)Small HER2-positive, node-negative breast cancer: who should receive systemic adjuvant treatment? Ann Oncol 22 17-3710
[8]
Joensuu H(2013)HER2/neu gene determination in women screened for breast carcinoma: how screening programs reduce the skyrocketing cost of targeted therapy Anticancer Res 33 3705-1344
[9]
Kellokumpu-Lehtinen PL(2009)Molecular characteristics of screen-detected vs symptomatic breast cancers and their impact on survival Br J Cancer 101 1338-4110
[10]
Huovinen R(2008)Molecular subtypes of breast cancers detected in mammography screening and outside of screening Clin Cancer Res 14 4103-714